COMPASS PATHWAYS PLC (CMPS) Reports the reporting period Financial Results
COMPASS PATHWAYS PLC (CMPS) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: Not disclosed
Net Income: 91202
EPS: Not disclosed
Cash and equivalents: 466010
FDA granted Compass NDA rolling submission and review request, based on strength of Phase 3 data
CNPV awarded for COMP360 in TRD, further accelerating momentum
week (Part B) data from COMP006, expected in early Q3 2026
📋 COMPASS PATHWAYS PLC (CMPS) - Financial Results
Filing Date: 2026-05-13
Accepted: 2026-05-13 06:30:53
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: